- By Leo
- 0 comments
19. Synthetic Cannabinoids: man-made Cannabis metabolites
Since the discovery of THC, the medical industry has been interested in studying the interactions between cannabinoids and the human endocannabinoid system (ECS). Synthetic cannabinoids (SCBs) have been developed to mimic the effects of natural cannabinoids, with thousands of compounds created. These chemicals have different structures and a higher affinity for ECS receptors, making them more potent than natural cannabinoids. They have been used in pharmacological studies and show potential for treating various medical conditions. However, they also have drawbacks such as unpredictable side effects and a higher risk for abuse.
Het Adriaan van Royen Instituut start, in samenwerking met PGMCG een wetenschappelijk onderzoek naar gebruikerservaringen met medicinale cannabis.
Het Adriaan van Royen Instituut start, in samenwerking met PGMCG een wetenschappelijk onderzoek naar gebruikerservaringen met medicinale cannabis.
Doelstelling Adriaan van Royen Insituut
De doelstelling van het Adriaan van Royen Instituut is […]
Medicinal plants in Brazil: Pharmacological studies, drug discovery, challenges and perspectives
Abstract This review article focuses on pre-clinical and clinical […]